Table 3:

Gadolinium deposition in skin samples from patients with NSF (adapted from Roberts et al³⁴)

Lead Author	No. of Patients with NSF	Range of Gadolinium Levels (μg/g)	No. of Controls	Range of Gadolinium Levels (μg/g)	Comment
Lead Author	No. of Patients with NSF	Range of Gadolinium Levels (μg/g)	No. of Controls	Range of Gadolinium Levels (μg/g)	Inductively Coupled Mass Spectrometry (ICP-MS) Techniques
High et al⁷	5	4.8–106	1	0	Limits of detection not provided
Khurana et al³⁵	6	57.2–717.8	2
			Infant Foreskin	0.0 (reported as ppm)
			2 Multiple Sclerosis Patients	0.1	3-5 Gadolinium MRIs 1 MS patient marginal renal function
			Scleroderma Patient	0.2

Christensen et al³⁶	13	Affected skin 6.3–348.7	13	2 − 0.1	2 with previous GBCA administration
Christensen et al³⁶	13	Unaffected skin 0.6–68.2	13	11 below detectable range
Roberts et al³⁴	1?	14.5			61 GBCA MRIs, eGFR >59 mL/min/1.73 m²